PL353273A1 - Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs - Google Patents

Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs

Info

Publication number
PL353273A1
PL353273A1 PL00353273A PL35327300A PL353273A1 PL 353273 A1 PL353273 A1 PL 353273A1 PL 00353273 A PL00353273 A PL 00353273A PL 35327300 A PL35327300 A PL 35327300A PL 353273 A1 PL353273 A1 PL 353273A1
Authority
PL
Poland
Prior art keywords
drugs
contrast agents
diagnostic imaging
bioactive substances
imaging contrast
Prior art date
Application number
PL00353273A
Other languages
English (en)
Polish (pl)
Inventor
Antonio Verdini
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of PL353273A1 publication Critical patent/PL353273A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/641Branched, dendritic or hypercomb peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL00353273A 1999-07-23 2000-07-21 Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs PL353273A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999FO000015A ITFO990015A1 (it) 1999-07-23 1999-07-23 "dendrimeri polipeptidici quali trasportatori unimolecolari di farmaci e sostanze biologicamente attive".
PCT/EP2000/007022 WO2001007469A2 (en) 1999-07-23 2000-07-21 Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs

Publications (1)

Publication Number Publication Date
PL353273A1 true PL353273A1 (en) 2003-11-03

Family

ID=11353680

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00353273A PL353273A1 (en) 1999-07-23 2000-07-21 Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs

Country Status (12)

Country Link
EP (1) EP1200461A2 (ja)
JP (1) JP2003506326A (ja)
CN (1) CN1364171A (ja)
AU (1) AU772167B2 (ja)
CA (1) CA2380178A1 (ja)
HU (1) HUP0201975A3 (ja)
IT (1) ITFO990015A1 (ja)
NO (1) NO20020333D0 (ja)
NZ (1) NZ517231A (ja)
PL (1) PL353273A1 (ja)
WO (1) WO2001007469A2 (ja)
ZA (1) ZA200201089B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY137259A (en) 2001-03-05 2009-01-30 Shell Int Research Process to prepare a lubricating base oil and a gas oil.
AR032941A1 (es) 2001-03-05 2003-12-03 Shell Int Research Un procedimiento para preparar un aceite base lubricante y aceite base obtenido, con sus diversas utilizaciones
MY139353A (en) 2001-03-05 2009-09-30 Shell Int Research Process to prepare a lubricating base oil and a gas oil
WO2003037383A1 (en) * 2001-10-29 2003-05-08 The Dow Chemical Company An antineoplastic- dendritic polymer drug delivery system
JP4629435B2 (ja) 2002-07-18 2011-02-09 シエル・インターナシヨネイル・リサーチ・マーチヤツピイ・ベー・ウイ 微結晶蝋及び中間蒸留物燃料の製造方法
EP1525890A1 (en) * 2003-10-02 2005-04-27 Complex Biosystems GmbH Protein-Proteophore complexes
EP1948271B1 (en) 2005-11-17 2013-10-02 Zogenix, Inc. Delivery of viscous formulations by needle-free injection
HUP0700782A3 (en) * 2007-12-05 2009-11-30 Biostatin Gyogyszerkutato Fejl Novel peptides and amino acid derivatives, pharmaceutical compositions containing the same and use of the compounds
CN102014625A (zh) 2008-04-28 2011-04-13 佐吉尼克斯股份有限公司 用于治疗偏头痛的新制剂
NZ591052A (en) * 2008-08-05 2012-11-30 Univ Queensland Antigen-presenting scaffolds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000540A1 (en) * 1993-06-18 1995-01-05 Robert Webber Synthetic carrier and immunogen
WO1998032469A2 (en) * 1997-01-29 1998-07-30 Nycomed Imaging As Polymers

Also Published As

Publication number Publication date
CN1364171A (zh) 2002-08-14
EP1200461A2 (en) 2002-05-02
NZ517231A (en) 2003-05-30
CA2380178A1 (en) 2001-02-01
HUP0201975A2 (en) 2002-10-28
NO20020333L (no) 2002-01-22
JP2003506326A (ja) 2003-02-18
ITFO990015A1 (it) 2001-01-23
AU772167B2 (en) 2004-04-08
ZA200201089B (en) 2003-07-30
WO2001007469A3 (en) 2001-05-10
NO20020333D0 (no) 2002-01-22
HUP0201975A3 (en) 2002-11-28
WO2001007469A2 (en) 2001-02-01
AU6276600A (en) 2001-02-13

Similar Documents

Publication Publication Date Title
HUP0203325A3 (en) Bicyclic amino acids, pharmaceutical compositions containing them and their use
CZ20012028A3 (cs) Nové N-substituované 2-kyanopyrrolidiny, farmaceutický prostředek, který je obsahuje a jejich použití jako léčivo
HUP0004400A3 (en) Dipeptide nitriles, process for their preparation, pharmaceutical compositions comprising thereof and their use
ZA200202996B (en) Hair treatment compositions comprising particulate substances.
HUP0204413A3 (en) Quinazoline compounds, their preparation, their use and pharmaceutical compositions containing them
HUP0100270A3 (en) Peptids for inhibiting betha-amyloid peptide release and/or its synthesis, pharmaceutical compositions comprising thereof and their use
HUP0200831A2 (en) Novel pharmaceutical composition containing amoxycillin and its use
EE200200046A (et) 8-fenüül-6,9-dihüdro-[1,2,4]triasolo[3,4-i]puriin-5-ooni derivaat, selle valmistamine ja raviotstarbeline kasutamine ning seda sisaldav farmatseutiline kompositsioon
HUP0103265A3 (en) Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use
HUP0204081A3 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
ZA971869B (en) Implants with phasewise release of pharmaceutical substance.
HUP0203194A3 (en) Phenylpiperazines, pharmaceutical compositions containing them and their use
HUP0202781A3 (en) Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
HUP0201975A3 (en) Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs
NZ513650A (en) Pharmaceutical composition for the treatment of urinary incontinence, motion sickness and vertigo
IL156262A0 (en) Anti-cd28 antibodies having no mitogenic activity and pharmaceutical compositions containing the same
ZA991974B (en) Bicyclic aromatic compounds and their use in human or veterinary medicine, as well as in cosmetology.
EP1210416A4 (en) GENES CODING PROTEINS FOR DIAGNOSTIC, PREVENTIVE AND THERAPEUTIC USE
HK1029928A1 (en) Pharmaceutical compositions of peptides having lowsolubility in physiological medium.
HUP0201910A3 (en) Novel aminobenzophenones, pharmaceutical compositions containing them and their use
IL152202A0 (en) Human kcnq5 polypeptide and pharmaceutical compositions containing the same
HUP0201696A2 (en) Cyclic peptides, pharmaceutical compositions comprising thereof and their use
ZA200109989B (en) Pharmaceutical composition containing sibutramine and orlistat.
DE69831223D1 (de) Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52
IL121329A (en) Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)